Tower Research Capital LLC (TRC) - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,030
-54.9%
16,493
+4.1%
0.00%
Q2 2023$11,158
+74286.7%
15,850
-3.9%
0.00%
Q1 2023$15
+66.7%
16,485
+112.3%
0.00%
Q4 2022$9
-100.0%
7,764
+137.5%
0.00%
Q3 2022$25,000
-10.7%
3,269
-26.7%
0.00%
-100.0%
Q2 2022$28,000
-51.7%
4,458
-35.4%
0.00%0.0%
Q1 2022$58,000
-60.0%
6,900
-75.3%
0.00%
-66.7%
Q4 2021$145,000
-18.5%
27,976
+5.0%
0.00%
-40.0%
Q3 2021$178,000
+836.8%
26,633
+1121.1%
0.01%
Q2 2021$19,000
+35.7%
2,181
+39.8%
0.00%
Q1 2021$14,000
-44.0%
1,560
-23.4%
0.00%
-100.0%
Q4 2020$25,000
-84.8%
2,037
-90.0%
0.00%
-50.0%
Q3 2020$165,000
+345.9%
20,301
+414.9%
0.00%0.0%
Q2 2020$37,0003,943
+6941.1%
0.00%
Q1 2020$0
-100.0%
56
-89.6%
0.00%
Q3 2019$5,000
-90.4%
536
-89.1%
0.00%
-100.0%
Q2 2019$52,000
+1200.0%
4,895
+1719.7%
0.00%
Q1 2019$4,000
-87.9%
269
-91.8%
0.00%
-100.0%
Q4 2018$33,000
+65.0%
3,289
+99.3%
0.00%
+100.0%
Q3 2018$20,000
+566.7%
1,650
+579.0%
0.00%
Q2 2018$3,000
-96.1%
243
-95.6%
0.00%
-100.0%
Q4 2017$77,000
+7600.0%
5,583
+3325.2%
0.01%
Q2 2017$1,000
-92.9%
163
-86.8%
0.00%
-100.0%
Q1 2017$14,000
+600.0%
1,236
+776.6%
0.00%
Q3 2016$2,000
+100.0%
141
+62.1%
0.00%
Q1 2016$1,000870.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders